Management of hemolytic uremic syndrome.
作者： Chantal Loirat , Jeffrey Saland , Martin Bitzan
DOI: 10.1016/J.LPM.2011.11.013
关键词: Atypical hemolytic uremic syndrome 、 Disease 、 Therapeutic approach 、 Plasmapheresis 、 Medicine 、 Shiga toxin producing 、 Population 、 Eculizumab 、 Pediatrics 、 Kidney transplantation
摘要: 2011 has been a special year for hemolytic uremic syndrome (HUS): on the one hand, dramatic epidemic of Shiga toxin producing E. coli -associated HUS in Germany brought disease to attention general population, other hand it when eculizumab, first complement blocker available clinical practice, was demonstrated as potential new standard care atypical HUS. Here we review therapeutic options presently various forms and show how recent knowledge changed approach prognosis
em-consulte.com
elsevier.com参考文章(144)
Thomas Bombeli, Aly Karsan, Jonathan F. Tait, John M. Harlan, Apoptotic vascular endothelial cells become procoagulant Blood. ,vol. 89, pp. 2429- 2442 ,(1997) , 10.1182/BLOOD.V89.7.2429
David Adams, Nuria Carrillo, Charles P Venditti, Disorders of Intracellular Cobalamin Metabolism University of Washington, Seattle. ,(2013)
Maren Sullivan, Zoran Erlic, Michael M. Hoffmann, Klaus Arbeiter, Ludwig Patzer, Klemens Budde, Bernd Hoppe, Martin Zeier, Karl Lhotta, Lisa A. Rybicki, Andreas Bock, Gani Berisha, Hartmut PH Neumann, Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome Annals of Human Genetics. ,vol. 74, pp. 17- 26 ,(2010) , 10.1111/J.1469-1809.2009.00554.X
W. Haller, D. V. Milford, T. H. J. Goodship, K. Sharif, D. F. Mirza, P. J. McKiernan, Successful Isolated Liver Transplantation in a Child with Atypical Hemolytic Uremic Syndrome and a Mutation in Complement Factor H American Journal of Transplantation. ,vol. 10, pp. 2142- 2147 ,(2010) , 10.1111/J.1600-6143.2010.03228.X
M. Noris, G. Remuzzi, Thrombotic Microangiopathy After Kidney Transplantation American Journal of Transplantation. ,vol. 10, pp. 1517- 1523 ,(2010) , 10.1111/J.1600-6143.2010.03156.X
Dorothea Orth, Abdul Basit Khan, Asma Naim, Katharina Grif, Jens Brockmeyer, Helge Karch, Michael Joannidis, Simon J. Clark, Anthony J. Day, Sonja Fidanzi, Heribert Stoiber, Manfred P. Dierich, Lothar B. Zimmerhackl, Reinhard Würzner, Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome Journal of Immunology. ,vol. 182, pp. 6394- 6400 ,(2009) , 10.4049/JIMMUNOL.0900151
Tatsuya Nakatani, Rikio Yoshimura, Kazunobu Sugimura, Yoshiaki Takemoto, Kenji Tsuchida, Plasma exchange therapy for the treatment of Escherichia coli O-157 associated hemolytic uremic syndrome. International Journal of Molecular Medicine. ,vol. 10, pp. 585- 588 ,(2002) , 10.3892/IJMM.10.5.585
K.P. Crookston, A.P. Reiner, L.J.N. Cooper, R.A. Sacher, M.A. Blajchman, N.M. Heddle, RBC T activation and hemolysis: implications for pediatric transfusion management Transfusion. ,vol. 40, pp. 801- 812 ,(2000) , 10.1046/J.1537-2995.2000.40070801.X
Sophie Ferlicot, Amélia Vernochet, Serge Romana, Monique Ortin-Serrano, Alexia Letierce, Olivier Brégerie, Antoine Durrbach, Catherine Guettier, Microchimerism in renal allografts: clinicopathological associations according to the type of chimeric cells. Histopathology. ,vol. 56, pp. 188- 197 ,(2010) , 10.1111/J.1365-2559.2009.03466.X
Christina Frank, Dirk Werber, Jakob P Cramer, Mona Askar, Mirko Faber, Matthias an der Heiden, Helen Bernard, Angelika Fruth, Rita Prager, Anke Spode, Maria Wadl, Alexander Zoufaly, Sabine Jordan, Markus J Kemper, Per Follin, Luise Müller, Lisa A King, Bettina Rosner, Udo Buchholz, Klaus Stark, Gérard Krause, None, Epidemic Profile of Shiga-Toxin–Producing Escherichia coli O104:H4 Outbreak in Germany The New England Journal of Medicine. ,vol. 365, pp. 1771- 1780 ,(2011) , 10.1056/NEJMOA1106483